TXG Stock Analysis: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$61.54
-3.31 (-5.10%)
▼
5d:
-5.5%
30d:
+24.5%
90d:
+117.42%
WAIT
LOW Confidence
Analysis Updated: Aug 28, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TXG shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TXG shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$9.90
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$6.15
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $61.54, which is considered extended relative to its 30-day fair value range of $46.67 to $61.38. From a valuation perspective, the stock is trading at a premium (Forward PE: 302.7) compared to its historical average (161.4). At these levels, the market is pricing in 23.3% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $55.25, while resistance sits at $66.94. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: TXG scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $49.54. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TXG is in a strong uptrend. Immediate support is located at $55.25, while resistance sits at $66.94. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: TXG scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $49.54. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$46.67 -
$61.38
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
9.5%
Protect Your Profits
Holding TXG? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.1%)
- BEARISH: Trading 19.5% above Wall St target ($49.54)
- BEARISH: Market expects 23.3% growth - appears too optimistic based on history
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$46.67 -
$61.38
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$55.25
Resistance Level
$66.94
Current Trend
Strong Uptrend
Technical data as of
Aug 28, 2026
Fundamental Context
Forward P/E (Next Year Est.)
302.71
Wall Street Target
$49.54
(-19.5%)
Revenue Growth (YoY)
-12.7%
Profit Margin
-12.2%
Valuation Premium vs History
+23.3% premium
PE vs Historical
302.7 vs 161.4
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+23.3%
(market-implied from PE analysis)
1-Year Target
$75.88
(+23%)
2-Year Target
$93.56
(+52%)
3-Year Target
$115.36
(+88%)
3-Yr Target (if PE normalizes)
(PE: 303→161)
PE COMPRESSION
$61.51
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 302.7, Growth: 93.6%)
$207.70
(+238%)
Base:
(SPY PE: 20.1, Growth: 93.6%)
$13.77
(-78%)
Bear:
(PE: 17.1, Growth: 93.6%)
$11.71
(-81%)
Share & Embed Analysis
Last updated: August 30, 2026 11:38 AM ET
Data refreshes hourly during market hours. Next update: 12:38 PM
Data refreshes hourly during market hours. Next update: 12:38 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Serge Saxonov
SELL
5000 shares
2026-04-14
Serge Saxonov
SELL
5000 shares
2026-03-24
Serge Saxonov
SELL
10000 shares
2026-03-23
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$294 | 45 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 48 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 58 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 42 HOLD |
|
BTSG
BrightSpring Health Serv… |
STRONG BUY
12 analysts |
$79 | 65 BUY |
Advanced TXG Option Strategies
Professional options setups generated by AI based on today's TXG price and gamma walls.
